pivekimab sunirine
immunogen
['cadenza', 'pivekimab', '$imgn']
$imgn presents updated findings from cadenza trial of pivekimab sunirine (cd123 adc) in bpdcn at #eha2023
may cutoff - n=79 / 30 1l+49 r/r *1l
orr [cr*+pr] 80% (24/30)
ccr 73% +1 cr post-xplant
mdor 12.7mo *r/r orr 33% (16/49)
ccr 20%
mdor 7.1mo no cls 
Biotellytics / https://t.co/37itIfRolp = business intel service on listed European Bios / Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design)